Tang Capital Management LLC Athira Pharma, Inc. Transaction History
Tang Capital Management LLC
- $1.17 Billion
- Q3 2024
A detailed history of Tang Capital Management LLC transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Tang Capital Management LLC holds 600,000 shares of ATHA stock, worth $438,000. This represents 0.02% of its overall portfolio holdings.
Number of Shares
600,000
Previous 1,052,715
43.0%
Holding current value
$438,000
Previous $2.79 Million
90.32%
% of portfolio
0.02%
Previous 0.34%
Shares
6 transactions
Others Institutions Holding ATHA
# of Institutions
66Shares Held
16.9MCall Options Held
112KPut Options Held
68K-
Perceptive Advisors LLC New York, NY5.4MShares$3.94 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.61MShares$1.18 Million0.0% of portfolio
-
Simplify Asset Management Inc. New York, NY1.49MShares$1.09 Million0.04% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.49MShares$1.09 Million0.39% of portfolio
-
Black Rock Inc. New York, NY676KShares$493,6580.0% of portfolio
About Athira Pharma, Inc.
- Ticker ATHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,817,700
- Market Cap $27.6M
- Description
- Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...